Abbott gets US antitrust approval to buy St. Jude Medical
Traders gather at the booth that trades Abbott Laboratories on the floor of the New York Stock Exchange, December 10, 2012. REUTERS/Brendan McDermid. By Diane Bartz | WASHINGTON. WASHINGTON Healthcare company Abbott Laboratories (ABT.
Abbott wins antitrust approval for St. Jude acquisition
Abbott gets green light from regulators on St. Jude acquisition
FTC Places Conditions on Abbott (ABT) Acquisition of St. Jude Medical (STJ)
View original article
Powered by WPeMatico